CSIMarket
 
Crinetics Pharmaceuticals Inc   (NASDAQ: CRNX)
 

Crinetics Pharmaceuticals Inc's Suppliers Performance

CRNX's Supply Chain




 
CRNX Costs vs Sales of Suppliers Growth Crinetics Pharmaceuticals Inc's cost of sales deteriorated by 0 % year on year, relative to one quarter ago cost of sales fell by -23 % in Q2.

• More on CRNX Suppliers



Crinetics Pharmaceuticals Inc's cost of sales deteriorated by 0 % year on year, compare to one quarter ago cost of sales fell by -23 % in Q2.

• More on CRNX Suppliers




Crinetics Pharmaceuticals Inc's Comment on Supply Chain


The company utilizes third-party manufacturers for raw materials, drug substances, and finished drug products used in preclinical research, clinical trials, and commercial activities. The drug substance for paltusotine is synthesized in India, optimized for bioavailability in Portugal, and tableted into the finished drug product in the United States. The company manages contract manufacturing organizations (CMOs) through internal staff and third-party consultants. Distribution of PALSONIFY in the United States is conducted via a third-party distributor, with sales, marketing, and distribution managed through a combination of internal resources and external partnerships.

Crinetics Pharmaceuticals Inc's Comment on Supply Chain


The company utilizes third-party manufacturers for raw materials, drug substances, and finished drug products used in preclinical research, clinical trials, and commercial activities. The drug substance for paltusotine is synthesized in India, optimized for bioavailability in Portugal, and tableted into the finished drug product in the United States. The company manages contract manufacturing organizations (CMOs) through internal staff and third-party consultants. Distribution of PALSONIFY in the United States is conducted via a third-party distributor, with sales, marketing, and distribution managed through a combination of internal resources and external partnerships.







CRNX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Crinetics Pharmaceuticals Inc 8,967.32 42.16 -501.61 594
SUBTOTAL 0.00 0.00 0.00 -


Sources: Crinetics Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Crinetics Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.